Ashley Yocum, PhD
Ashley Yocum, PhD, is the executive research strategy lead of the Beat AML Master Trial at the Leukemia & Lymphoma Society.
Articles
June 16th 2025
Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress
Brooke McCormick Marina Kremyanskaya, MD, PhD Lorna Warwick Xavier Leleu, MD, PhD Ashley Yocum, PhD Matthew Matasar, MD Adela Perolla, MD, PhD
At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.
June 15th 2025
Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD
At the European Hematology Association (EHA) 2025 Congress, Ashley Yocum, PhD, highlights how the Beat AML Master Trial advances safe, personalized treatment and expands targeted therapy options for patients with acute myeloid leukemia (AML).
Latest Updated Articles
Published: August 18th 2025 | Updated: August 25th 2025
Conditional Economic Incentives Could Be Effective in Improving Adherence to Long-Acting PrEP in Transgender Adults
Published: August 19th 2025 | Updated: August 22nd 2025
Semaglutide Not Associated With Increased Risk of Eye Disorders
Published: June 6th 2025 | Updated: August 18th 2025
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
Published: June 27th 2025 | Updated: July 1st 2025
Report Reveals Mounting Burdens of Drug Shortages on US Health System
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
